Company Filing History:
Years Active: 2017
Title: **Inventor Yongbi Chen and His Innovative Contributions to Valsartan Refinement**
Introduction
Yongbi Chen, based in Taizhou, China, is recognized for his significant contribution to the pharmaceutical industry through his innovative methods. With a focus on refining valsartan, a medication used primarily for treating high blood pressure, Yongbi has secured one notable patent that demonstrates his commitment to advancing pharmaceutical techniques.
Latest Patents
Yongbi Chen holds a patent titled "Method of refining valsartan comprising more than or equal to 10% D-isomers." This invention outlines a method that involves dissolving valsartan that contains a high proportion of D-isomers in a solvent, followed by the addition of an inorganic base. The process includes separating solids after salification, distilling the filtrate to remove organic solvents, adjusting the pH, and ultimately crystallizing the product. The outcome of this method results in isomer levels being reduced to below 0.5% and achieving a yield of at least 40%, proving to be suitable for industrial production.
Career Highlights
Yongbi Chen works at Zhejiang Huahai Pharmaceutical Co., Ltd., where he has been pivotal in research and development. His work not only enhances product quality but also contributes to the efficiency of pharmaceutical manufacturing processes. His innovative methods have the potential to influence future practices in the industry.
Collaborations
At Zhejiang Huahai Pharmaceutical Co., Ltd., Yongbi collaborates with esteemed colleagues such as Wenling Zhang and Peng Wang. This collaboration fosters a dynamic working environment where innovative ideas and techniques can be shared and developed collectively, leading to further advancements in pharmaceutical sciences.
Conclusion
Yongbi Chen's dedication to innovation in valsartan refinement illustrates the critical role inventors play in the pharmaceutical industry. With his patented method and collaboration with talented researchers, Yongbi continues to make strides that enhance the quality and efficiency of medication production, paving the way for future innovations.